Skip to main content

Longeveron Inc.

LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001721484

No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Longeveron Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of LGVN: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders2119−2
Shares801.8K585.4K−216.3K (−27.0%)
Value$2.71M$1.37M−$1.34M (−49.5%)

New holders (5)

Institutions that held Longeveron Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to LGVN in Q3 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC20,421$47.4K0.00%
Lloyd Advisory Services, LLC.14,450$33.8K0.01%
Norden Group LLC14,450$33.8K0.01%
LGT Financial Advisors LLC357$8350.00%
Householder Group Estate & Retirement Specialist, LLC100$2340.00%

Sold out (7)

Institutions that held Longeveron Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of LGVN in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Yakira Capital Management, Inc.85,000$287.3K
Boothbay Fund Management, LLC75,000$253.5K
Alpine Global Management, LLC75,000$253.5K
Susquehanna International Group, LLP18,513$62.6K
Sea Otter Advisors LLC13,416$45.3K
Bank of America Corp2,774$9.38K
UBS Group AG129$436